![]() |
市場調査レポート
商品コード
1714664
乳房画像診断市場:製品、技術、装置タイプ、カテゴリー、画像モダリティ、用途、エンドユーザー別-2025-2030年の世界予測Breast Imaging Market by Product, Technology, Equipment Type, Category, Imaging Modality, Application, End-User - Global Forecast 2025-2030 |
||||||
カスタマイズ可能
適宜更新あり
|
乳房画像診断市場:製品、技術、装置タイプ、カテゴリー、画像モダリティ、用途、エンドユーザー別-2025-2030年の世界予測 |
出版日: 2025年04月01日
発行: 360iResearch
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
|
乳房画像診断市場の2024年の市場規模は54億米ドルで、2025年には58億3,000万米ドル、CAGR 8.24%で成長し、2030年には86億9,000万米ドルに達すると予測されています。
主要市場の統計 | |
---|---|
基準年 2024年 | 54億米ドル |
推定年 2025年 | 58億3,000万米ドル |
予測年 2030年 | 86億9,000万米ドル |
CAGR(%) | 8.24% |
乳房画像は、診断精度と患者管理の両方に革命をもたらし、現代医療の展望を再定義し続けています。この広範なレポートでは、現在の市場力学、新たな技術、産業を前進させる革新的なソリューションについて詳細に検証しています。画像診断モダリティとソフトウェアソリューションの進歩がシステム機能の向上と融合するにつれ、利害関係者には前例のない成長機会と患者転帰の向上がもたらされています。
本概要では、変革的な市場シフト、複雑なセグメンテーション分析、世界の地域動向といった包括的なテーマを明確かつ体系的に解き明かしています。また、デジタルマンモグラフィや分子イメージングなどの高精度モダリティに焦点を当てることで、乳房画像セグメントにおける課題と機会の両方を浮き彫りにしています。画像診断センターから大病院に至るまで、多様なアプリケーションとエンドユーザーを網羅し、さらなる詳細な探求の舞台を記載しています。
この採用は、画像戦略の進化、市場の促進要因の詳細なセグメンテーション、産業全体の標準を形成している地域や企業洞察などを丹念に取り上げた後続セクションへの採用として機能します。読者は、思慮深い分析、責任ある予測、実行可能な提言に出会い、現在のシナリオを要約するだけでなく、乳房画像診断における将来の革新の軌跡を描くことができます。
乳房画像診断の変革:新たな動向と市場の進化
乳房画像診断における技術革新はパラダイムシフトを引き起こし、標準治療を再認識させる変革的動向への道を開いています。最近の進歩は、改良された画像処理システムと先進的ソフトウェア統合を融合させ、診断精度の向上と患者管理手順の合理化をもたらしています。この進化の特徴は、リアルタイムデータ処理への依存の高まり、画像処理ソフトウェアと統合された人工知能アルゴリズム、優れた解像度と処理速度をもたらすハードウェアの改良です。
技術的背景を深く掘り下げると、伝統的二次元イメージングが三次元、さらには4次元イメージング機能によって急速に補完され、多くの場合、凌駕されつつある傾向が明らかになります。この進歩は、診断精度を向上させるだけでなく、臨床医が患者ケアの重要な時点で、より多くの情報に基づいた意思決定を行えるようにします。さらに、放射線被曝の最小化と画質の最大化が重視されるようになり、このバランスは、デジタル画像とアナログ画像の両セグメントにおける反復的な技術革新によって達成されています。
さらに、この変革期は、診断機能と治療機能の融合によって特徴づけられます。例えば、かつては診断ツールとしてのみ作動していたシステムは、現在ではインターベンション手技の際にガイダンスを提供するように進化しており、それによって診断と治療の間のギャップを埋めています。画像データをインテリジェントに管理し、読影を支援する最先端のソフトウェアソリューションの導入も、この移行を加速する要因のひとつです。その結果、包括的でユーザー中心のアプローチが産業のベンチマークを再定義し、多様な医療環境における乳房画像診断の実施方法に新たな基準を設定することになりました。
継続的な研究と強固な技術プラットフォームへの戦略的投資を通じて、乳房画像市場はその能力をさらに拡大させようとしています。産業では、従来の手法から、より統合的で多次元的な画像ソリューションへの積極的なシフトが見られ、その結果、医療提供プロセス全体が強化されています。
市場成長を促進する詳細なセグメンテーション洞察
乳房画像市場の包括的なセグメンテーションにより、多面的な分析層が明らかになり、それぞれが市場の複雑な力学をより明確に理解することに貢献しています。製品によるセグメンテーションでは、ソフトウェアとシステムセグメントの製品を調査することで市場を差別化します。ソフトウェアセグメントでは、画像診断ソフトウェアと放射線診断ソフトウェアに分類され、それぞれが現代の診断ワークフローにおいて極めて重要な役割を担っています。さらに、システムセグメントでは、生検ガイダンスシステム、乳房MRIシステム、乳房超音波システム、マンモグラフィシステム、トモシンセシスシステムなどの特殊なアプリケーションを分析し、画像ソリューションの全体像を把握します。
市場セグメンテーションでは、2D、3D、4Dイメージングに区分され、従来のイメージング手法から、より高い精度と臨床的有用性を提供する先進的な多次元プラットフォームへの移行が強調されています。機器タイプ別では、統合システム、モバイルユニット、スタンドアロン機器にさらに分類され、固定された臨床現場から柔軟なポイントオブケアソリューションまで、多様な運用ニーズに対応しています。このセグメンテーションは、市場の強固なイノベーションと展開ソリューションの適応性を強調するものです。
さらに、このセグメントはアナログ画像とデジタル画像を区別する基本的なカテゴリーに基づいてセグメント化されており、歴史的な進化と医療におけるデジタル変革に向けた現在の推進力を反映しています。画像モダリティによるセグメンテーションは、乳房トモシンセシス、造影強化マンモグラフィ、デジタルマンモグラフィ、磁気共鳴画像法、分子乳房画像法、超音波画像法などの特殊技術に関する洞察を記載しています。各モダリティはそれぞれ異なる臨床的利点を提供し、患者固有のニーズと診断基準に基づいて選択されます。
さらに、乳房生検、診断用マンモグラフィ、術前ローカライゼーション、検診用マンモグラフィなど、アプリケーションのプリズムを通して市場を検証することで、さらに深みを増すことができます。この分析は、ダイナミックな使用事例がいかに需要と技術革新を促進するかを示しています。最後に、外来手術センター、がん研究センター、画像診断センター、病院を含むエンドユーザー別セグメンテーションは、乳房画像技術の適用範囲の広さを示すとともに、さまざまな医療環境のニーズに対応するカスタマイズ型ソリューションの重要性を強調しています。
TAB
The Breast Imaging Market was valued at USD 5.40 billion in 2024 and is projected to grow to USD 5.83 billion in 2025, with a CAGR of 8.24%, reaching USD 8.69 billion by 2030.
KEY MARKET STATISTICS | |
---|---|
Base Year [2024] | USD 5.40 billion |
Estimated Year [2025] | USD 5.83 billion |
Forecast Year [2030] | USD 8.69 billion |
CAGR (%) | 8.24% |
Breast imaging continues to redefine the landscape of modern healthcare as it revolutionizes both diagnostic precision and patient management. In this expansive report, we deliver a detailed examination of the current market dynamics, emerging technologies, and innovative solutions that are propelling the industry forward. As advancements in imaging modalities and software solutions converge with improved system capabilities, stakeholders are presented with unprecedented opportunities for growth and enhanced patient outcomes.
In this summary, the overarching themes of transformative market shifts, intricate segmentation analyses, and global regional trends are unpacked in a clear, systematic manner. The narrative provides an introspective look into how cutting-edge software and systems are bolstering imaging processes, while a sharp focus on high-precision modalities such as digital mammography and molecular imaging underscores both the challenges and opportunities within the breast imaging space. The discussion spans across a diverse set of applications and end-users, ranging from diagnostic imaging centers to major hospitals, setting the stage for further detailed exploration.
This introduction serves as a prelude to the subsequent sections, which meticulously address the evolution of imaging strategies, the granular segmentation of market drivers, and regional as well as corporate insights that are shaping overall industry standards. Readers will encounter thoughtful analysis, responsible forecasting, and actionable recommendations that not only encapsulate the present scenario but also outline the trajectory for future innovations in breast imaging.
Transformative Shifts in Breast Imaging: Emerging Trends and Market Evolution
Technological innovation in breast imaging is catalyzing a paradigm shift, paving the way for transformative trends that reconceptualize the standard of care. Recent advancements have amalgamated improved imaging systems with sophisticated software integration, resulting in enhanced diagnostic accuracy and streamlined patient management procedures. The evolution is characterized by an increased reliance on real-time data processing, artificial intelligence algorithms integrated with imaging software, and refinements in hardware that yield superior resolution and faster processing speeds.
A deeper dive into the technological landscape reveals a trend where traditional two-dimensional imaging is rapidly being complemented, and in many cases, surpassed by three-dimensional and even four-dimensional imaging capabilities. This progression not only improves diagnostic precision but also empowers clinicians to engage in more informed decision-making at critical points in patient care. Additionally, there is a growing emphasis on minimization of radiation exposure coupled with maximized image quality, a balance achieved through iterative innovations in both digital and analog imaging categories.
Furthermore, this period of transformative change is marked by the convergence of diagnostic and therapeutic functions. For instance, systems that once operated solely as diagnostic tools are now evolving to offer guidance during interventional procedures, thereby bridging the gap between diagnosis and treatment. The infusion of cutting-edge software solutions that intelligently manage imaging data and assist in interpretation is another factor accelerating this transition. The result is a comprehensive, user-centric approach that redefines industry benchmarks and sets new standards for how breast imaging is performed across diverse healthcare environments.
Through continuous research and strategic investments in robust technology platforms, the breast imaging market is set to further expand its capabilities. The industry is witnessing an active shift from conventional practices towards more integrative, multi-dimensional imaging solutions which, in turn, enhance the overall healthcare delivery process.
Detailed Segmentation Insights Driving Market Growth
A comprehensive segmentation of the breast imaging market reveals multifaceted layers of analysis, each contributing to a clearer understanding of the market's intricate dynamics. The segmentation based on product differentiates the market by studying offerings in the fields of software and systems. The software dimension is further refined into imaging software and radiology software, each playing a pivotal role in modern diagnostic workflows. Complementarily, the systems segment is dissected to uncover the specialized applications within biopsy guidance systems, breast MRI systems, breast ultrasound systems, mammography systems, and tomosynthesis systems, collectively offering a panoramic view of imaging solutions.
When evaluated through the lens of technology, the market is segmented into areas of 2D, 3D, and 4D imaging, highlighting a transition from traditional imaging methods to advanced, multi-dimensional platforms that deliver higher accuracy and greater clinical utility. The equipment type segmentation further categorizes the offerings into integrated systems, mobile units, and standalone devices, thereby addressing diverse operational needs from fixed clinical settings to flexible point-of-care solutions. This segmentation accentuates the market's robust innovation and the adaptive nature of deployed solutions.
Moreover, the sector is segmented based on the underlying category which distinguishes between analog imaging and digital imaging, reflecting the historical evolution as well as the current thrust towards digital transformation in healthcare. A segmentation based on imaging modality provides insights into specialized techniques including breast tomosynthesis, contrast enhanced mammography, digital mammography, magnetic resonance imaging, molecular breast imaging, and ultrasound imaging. Each modality offers distinct clinical benefits and is chosen based on patient-specific needs and diagnostic criteria.
Further depth is achieved by examining the market through the prism of application, where the focus spans breast biopsy, diagnostic mammography, pre-surgical localization, and screening mammography. This analysis illustrates how dynamic use cases drive demand and innovation. Lastly, segmentation by end-user-encompassing ambulatory surgical centers, cancer research centers, diagnostic imaging centers, and hospitals-demonstrates the wide applicability of breast imaging technologies and underscores the importance of tailored solutions that address the needs of varied healthcare environments.
Based on Product, market is studied across Software and Systems. The Software is further studied across Imaging Software and Radiology Software. The Systems is further studied across Biopsy Guidance Systems, Breast MRI Systems, Breast Ultrasound Systems, Mammography Systems, and Tomosynthesis Systems.
Based on Technology, market is studied across 2D Imaging, 3D Imaging, and 4D Imaging.
Based on Equipment Type, market is studied across Integrated Systems, Mobile Units, and Standalone Devices.
Based on Category, market is studied across Analog Imaging and Digital Imaging.
Based on Imaging Modality, market is studied across Breast Tomosynthesis, Contrast Enhanced Mammography, Digital Mammography, Magnetic Resonance Imaging, Molecular Breast Imaging, and Ultrasound Imaging.
Based on Application, market is studied across Breast Biopsy, Diagnostic Mammography, Pre-Surgical Localization, and Screening Mammography.
Based on End-User, market is studied across Ambulatory Surgical Centers, Cancer Research Centers, Diagnostic Imaging Centers, and Hospitals.
Regional Insights: Navigating Global Trends in Breast Imaging
A geographic analysis of the breast imaging market emphasizes the significant role played by regional differences in shaping both market strategy and implementation. Emerging dynamics in the Americas underscore a mature landscape where innovation converges with a strong emphasis on patient-centric models. Here, technology adoption is at an all-time high, driven by high investments in digital imaging infrastructures and advanced diagnostic capabilities.
Across Europe, the Middle East, and Africa, market developments are witnessing a fusion of traditional imaging practices with modern technology. The integration of cutting-edge imaging solutions within this region is being accelerated by government initiatives, substantial research funding, and collaborative ventures between public and private healthcare entities. Meanwhile, these regions maintain a balanced approach by preserving elements of conventional diagnostic methodologies while progressively adopting innovative imaging systems that improve clinical outcomes.
In the Asia-Pacific region, the market is characterized by rapid growth fueled by both increasing healthcare expenditure and a rising awareness of early cancer detection. The region's trajectory is further enhanced by an upsurge in investments in healthcare infrastructure and a strong governmental backing for advancing technological capabilities. The combined prowess of these regions reinforces a vibrant global demand for breast imaging solutions, each contributing unique perspectives and strategic insights to the global market mosaic.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Market Leaders Shaping the Breast Imaging Industry
Key players in the breast imaging market have carved out prominent positions by consistently demonstrating a commitment to technological innovation and comprehensive service delivery. Industry leaders such as Agfa-Gevaert Group and Analogic Corporation have set benchmarks through their extensive portfolios that cover a broad array of imaging systems and software tools. Entities like Aurora Health, Inc. and Canon Inc. have further elevated market standards by integrating next-generation solutions that enhance both image quality and diagnostic speed.
Other significant contributors include Carestream Health Inc. and CMR Naviscan Corporation, which have been instrumental in driving advancements in imaging modalities and system integrations. Medical technology firms including Delphinus Medical Technologies, Inc. and EIZO Corporation continue to push boundaries in imaging clarity and workflow efficiency. Esteemed names such as Elekta AB and Esaote S.p.A. endorse sophisticated technological progress, exemplified by their investment in research and state-of-the-art imaging equipment.
Additional industry influencers such as FUJIFILM Holdings Corporation, GE HealthCare, and Hitachi Ltd. have redefined imaging standards by deploying innovative diagnostic solutions that balance precision with operational efficiency. Leaders like Hologic, Inc. and IMS Giotto S.p.A. complement these efforts through continuous product improvements and robust post-market support. International giants including Konica Minolta, Inc. and Koninklijke Philips N.V. play crucial roles in embedding electronics into medical workflows that make imaging both seamless and precise. Meanwhile, rapidly advancing companies such as Micrima Limited and Mindray Medical International Limited, supported by the technological acumen of Neusoft Medical Systems Co., Ltd., drive vital insights into modern diagnostic paradigms.
The market is further enriched by renowned organizations like Planmeca OY and Samsung Electronics Co., Ltd., partnered with specialists such as Sectra AB and Shanghai United Imaging Healthcare Co., LTD. The legacy of innovation is sustained by Shimadzu Corporation, Siemens Healthineers AG, Sonosdetect LLC, and Trivitron Healthcare Private Limited, all collaborating in an ecosystem that fosters constant technological breakthroughs and clinical advancements in breast imaging.
The report delves into recent significant developments in the Breast Imaging Market, highlighting leading vendors and their innovative profiles. These include Agfa-Gevaert Group, Analogic Corporation, Aurora Health, Inc., Canon Inc., Carestream Health Inc., CMR Naviscan Corporation, Delphinus Medical Technologies, Inc., EIZO Corporation, Elekta AB, Esaote S.p.A., FUJIFILM Holdings Corporation, GE HealthCare, Hitachi Ltd., Hologic, Inc., IMS Giotto S.p.A., Konica Minolta, Inc., Koninklijke Philips N.V., Micrima Limited, Mindray Medical International Limited, Neusoft Medical Systems Co., Ltd., Planmeca OY, Samsung Electronics Co., Ltd., Sectra AB, Shanghai United Imaging Healthcare Co., LTD, Shimadzu Corporation, Siemens Healthineers AG, Sonosdetect LLC, and Trivitron Healthcare Private Limited. Strategic Recommendations for Advancing in Breast Imaging
With the evolving dynamics of the breast imaging market, strategic recommendations for industry leaders are essential to navigate the complexities of technological integration and competitive differentiation. Stakeholders should prioritize continuous investment in research and development while embracing the dual imperatives of precision and efficiency. Embracing advanced imaging modalities not only enhances diagnostic accuracy but also contributes significantly to streamlined workflows and improved patient outcomes.
Leaders in the industry are advised to build robust partnerships with technology innovators and healthcare institutions. In doing so, they can harness unique insights to drive forward the adoption of integrated solutions that leverage both digital and analog imaging benefits. Investment in modernizing existing infrastructure with a focus on system interoperability is another key step, as it enables a seamless transition from legacy practices to cutting-edge imaging solutions. Furthermore, industry players should consider the strategic expansion of mobile and standalone imaging devices to cater to diverse clinical settings, ranging from high-volume diagnostic centers to specialized ambulatory surgical facilities.
To stay ahead in a competitive landscape, decision-makers should also explore avenues for strategic collaborations with academic and research institutions. Such partnerships can yield beneficial insights into upcoming imaging technologies and foster an environment primed for innovation. Moreover, a commitment to meeting regional regulatory requirements and adapting to local market nuances will prove critical in scaling operations on a global stage. By aligning long-term goals with evolving clinical needs and technological advancements, industry leaders can cement their position at the forefront of the breast imaging revolution.
Executive Summary Conclusion: Strategic Outlook and Future Directions
In conclusion, the breast imaging market is experiencing a transformative phase characterized by rapid technological advances and evolving diagnostic methodologies. The detailed segmentation analysis demonstrates the complexity and specificity of imaging solutions catering to diverse applications and end-users. The convergence of sophisticated imaging software with next-generation hardware is not only setting new clinical standards but also creating a fertile environment for innovation.
Global dynamics reveal that while mature markets in the Americas drive technological adoption, regions across Europe, the Middle East, Africa, and Asia-Pacific are rapidly embracing transformative strategies to meet both emerging and longstanding healthcare needs. Similarly, the competitive edge maintained by industry leaders through continuous innovation and customer-centric approaches emphasizes the importance of maintaining a forward-thinking strategy. Overall, a balanced approach that fuses technological innovation with strategic market positioning is imperative to sustaining long-term growth in the breast imaging field.
This report has thoroughly examined the nuances that define the current state of the market while also illuminating the pathways for future development. With an integrated view of both macroeconomic trends and micro-level segmentation insights, the comprehensive analysis underscores an optimistic outlook for the future of breast imaging.